Oxeltis team will be participating for the 3rd consecutive year to BIO-Europe Spring and is looking forward meeting you in Turin – Italy (March 10 - 12, 2014), to discuss your current and future (...)
Oxeltis team is participating to RARE 2013 and is looking forward meeting you in Montpellier-France (November 28-29 2013), to discuss your current and future projects involving medicinal chemistry and custom synthesis. Request a meeting at contact@oxeltis.com or use (...)
Dear all, Oxeltis team will be participating for the 3rd consecutive year to BIO Europe Conference and is looking forward meeting you in Vienna - Autria (November 4-6, 2013), to discuss (...)
Oxeltis will be present at EIC 2013 (Montpellier, France; September 25-27, 2013). We would be happy to meet you during the partnering cessions and discuss your current and future medicinal chemistry projects (...)
Oxeltis will be present at ChemOutsourcing 2013 (Ocean Place Resort, NJ, USA, September 17-19, 2013). We would be happy to meet you during the partnering cessions and discuss your current and future (...)
Oxeltis was pleased to sponsor the Gordon Research Conference (Nucleosides, Nucleotides & Oligonucleotides, June 30 - July 5, 2013) in Salve Regina University, Newport, RI, USA.
Oxeltis will be present at RICT 2013 (Nice- France, July 3-5, 2013). We would be happy to invite you at Oxeltis booth #37 to discuss your current and future projects involving medicinal chemistry and small (...)
Dear all, Oxeltis team would be happy to meet you at the 26th International Conference on Antiviral Research (ICAR 2013, San-Francisco, CA-USA: May 11th- 15th, 2013), to discuss your current and (...)
Oxeltis will be present at BIO International convention (Chicago, April 22-25, 2013). We would be happy to meet you to discuss your current and future projects involving medicinal chemistry (heterocycles, macrocycles, nucleos(t)ides…) (...)
Oxeltis will be present at Bio Europe 2012 (Hamburg, November 12-14, 2012). We would be happy to meet you to discuss your current and future projects involving small molecule custom synthesis and (...)